| EPE303 | Perceptions of older people living with hiv towards alcohol consumption and haart adherence in Southwestern Uganda | E-poster | Systems serving underserved populations |
| EPD312 | Perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda | E-poster | Other behavioural approaches |
| EPE273 | Performance assessment: an approach to achieving HIV epidemic control in Nigeria | E-poster | Approaches to supporting resilient health systems |
| EPB013 | Performance evaluation of home-based caregiver-assisted oral HIV screening of children compared to facility-based confirmatory testing using the national algorithm in Uganda | E-poster | Diagnosis of HIV disease in paediatric and adolescent populations |
| EPB014 | Performance evaluation of the point-of-care m-PIMA HIV-1/2 Viral Load assay in two South African clinics | E-poster | Viral load and CD4 monitoring |
| EPB191 | Periconceptional dolutegravir use and risk of adverse pregnancy outcomes in Kenya | E-poster | Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications |
| EPC342 | Periodic HIV Index Case Testing: a worthwhile approach to reach 'the unreached' in the journey to epidemic control | E-poster | Community-based HIV testing strategies |
| PEMOA30 | Persistent AP-1-induced immune activation during early SARS-CoV-2 infection revealed by simultaneous single-cell epigenetic and gene expression profiling | Poster exhibition | Immune responses to SARS-Cov2 |
| EPA033 | Persistent dysregulation of Vδ1 T lymphocytes in ART-suppressed people living with HIV | E-poster | Cellular immunity; T cell vaccines |
| PEMOB27 | Persistent low-level viremia in the era of dolutegravir in four African countries | Poster exhibition | Adherence |